← Leaderboards
Susan Audrey Hall
New England Research Institutes, Inc.
$1,144,784
Attributed
$1,144,784
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $407.7K · FY2009–12$500K$375K$250K$125K$0
'09
'10
'11
'12
Funding mix
By agency
NIH$1,144,784 · 3
By mechanism
R21$715,104 · 2
R01$429,680 · 1
Top collaborators
No co-investigators on record.
Most similar at New England Research Institutes, Inc.
Same institution · by research overlap
- Susan Jick$579,556
- Catherine B Johannes$1,131,747
- Andre B. Araujo$3,726,863
- Maria Irene Van Rompay$296,068
- Shona C Fang$137,688
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesPharmaceutical PreparationsPublicationsSafetyIncidencePharmacoepidemiologyManuscriptsProductivityRecording Of Previous EventsCostPublic Health RelevanceFollow-UpMaleDesignBaseBiometryGeographic LocationsDatabasesGrowthMalignant Breast NeoplasmClinical TrialsCohort StudiesElectronicsHormone Therapy
Grant awards (7)
Chemoprevention of Prostate Cancer$170,880
R01 · FY2012 · AG · contact PI
Exogenous Testosterone and Risk of Cancer$118,145
R21 · FY2012 · CA · contact PI
Chemoprevention of Prostate Cancer$258,800
R01 · FY2011 · AG · contact PI
Exogenous Testosterone and Risk of Cancer$1
R21 · FY2011 · CA · contact PI
Exogenous Testosterone and Risk of Cancer$213,150
R21 · FY2010 · CA · contact PI
Pharmacoepidemiology of Urologic Symptoms$194,594
R21 · FY2010 · DK · contact PI
Pharmacoepidemiology of Urologic Symptoms$189,214
R21 · FY2009 · DK · contact PI